logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Durvalumab/nivolumab/pembrolizumabVarious toxicities: 5 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2018年 / 1683卷 / 1期
关键词:
D O I:
10.1007/s40278-018-40210-y
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:273 / 273
相关论文
共 50 条
  • [31] Nivolumab/pembrolizumabVarious toxicities: 2 case reports
    Reactions Weekly, 2023, 1940 (1) : 342 - 342
  • [32] Nivolumab/pembrolizumabVarious toxicities: 9 case reports
    Reactions Weekly, 2019, 1758 (1) : 258 - 258
  • [33] Nivolumab/pembrolizumabVarious toxicities: 13 case reports
    Reactions Weekly, 2021, 1863 (1) : 278 - 278
  • [34] Nivolumab/pembrolizumabVarious toxicities: 13 case reports
    Reactions Weekly, 2020, 1799 (1) : 295 - 295
  • [35] Nivolumab/pembrolizumabVarious toxicities: 7 case reports
    Reactions Weekly, 2020, 1802 (1) : 225 - 225
  • [36] Nivolumab/pembrolizumabVarious toxicities: 16 case reports
    Reactions Weekly, 2019, 1770 (1) : 313 - 313
  • [37] Nivolumab/pembrolizumabVarious toxicities: 10 case reports
    Reactions Weekly, 2022, 1918 (1) : 392 - 392
  • [38] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 14 case reports
    Reactions Weekly, 2022, 1907 (1) : 271 - 271
  • [39] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 29 case reports
    Reactions Weekly, 2021, 1859 (1) : 201 - 201
  • [40] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 18 case reports
    Reactions Weekly, 2023, 1957 (1) : 315 - 315
← 12345 →